Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease

The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR gene-editing technology to inactivate the gene that codes for the protein driving this rare disease. The post Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a…

Read More

Innovation Fatigue is Rampant: What’s the Rx to Fix It?

It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care.  The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.

Read More

A Bite, a Bill, and a Bureaucratic Chill in Winning Halloween Haikus

Nearly 100 health care-themed haikus crept into our inbox this Halloween. See the winning poems and top runners-up from KFF Health News’ seventh annual Halloween haiku contest, illustrated by Oona Zenda. The judges’ favorites were inspired by tick migration, Medicaid work requirements, and rising copays. Follow KFF Health News’ social media accounts (X, Instagram, and…

Read More